Pharmafile Logo

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Mere View Barn, Park Lane, Pickmere, Knutsford, WA16 0LG, UK
+44 1565 733 772

 Latest Content from PMHub 

Amplifying Data Science Tools for End-to-End eClinical Solutions

Andreas Weber, Group CEO, EvidentIQ, discusses hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing...

Virtual meeting technologies for reducing emissions and waste in the healthcare industry

Read the full article here or on the Green Business Bureau blog for more details.

Climbing my own Lucid Ladder

Transforming lives. That’s what Lucid is all about. I knew that even before I stepped through the fabled door of ‘Towers’ on a chilly January morning in 2019. It’s why...

A Lucid Thirsty Thursday D&I Special

Last week’s ‘Thirsty Thursday’ session was organised by the Lucid Group D&I Committee, whose goal is to foster a culture where diversity and inclusivity are embedded and practised within all...

Diversity in clinical trials: looking back at our 2021 blogs

In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021

Gamifying Surgical Training to Improve Patient Outcomes

Dr. Justin Barad, CEO and Founder of Osso VR, explores how VR and gamification are revolutionizing surgical training by providing accurate quantitative assessments and analytics before performing on a patient....

Connecting capabilities in healthcare communications

The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated,...

Connecting capabilities in healthcare communications

The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated,...

What does the future hold for Light-chain Amyloidosis?

White Papers and Resources | December 1, 2021 | Inizio

Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...